Veru partners with Novo Nordisk for obesity drug combination study Jun 4, 2026 08:42AM
Veru, Inc. (VERU) Misses Q2 EPS by 13c May 13, 2026 06:41AM
Veru, Inc. (VERU) files $200M mixed shelf Apr 7, 2026 04:21PM
Veru, Inc. (VERU) files for 23.8M share offering by selling stockholders Apr 7, 2026 04:16PM
Veru, Inc. (VERU) reported Q1 EPS Feb 11, 2026 07:36AM


Dec 18, 2025 05:05AM Canaccord Genuity Starts Veru, Inc. (VERU) at Buy
Dec 18, 2025 04:14AM Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
Dec 17, 2025 06:31AM Veru reports fiscal 2025 results, plans obesity drug trial
Sep 23, 2025 08:30AM Veru receives FDA clarity on enobosarm obesity drug development pathway
Aug 13, 2025 02:39PM Veru, Inc. (VERU) PT Raised to $25 at Oppenheimer
Aug 13, 2025 05:30AM Veru, Inc. (VERU) PT Lowered to $20 at Raymond James
Aug 12, 2025 06:30AM Veru, Inc. (VERU) Misses Q3 EPS by 45c
Aug 11, 2025 04:01PM Veru selects Laxxon's SPID technology for enobosarm formulation
Aug 11, 2025 08:30AM Veru selects modified release enobosarm formulation for weight loss
Jun 24, 2025 08:30AM Veru, Inc. (VERU) Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study
May 28, 2025 06:33AM Veru, Inc. (VERU) Reports Positive Safety Results from Phase 2b QUALITY Study:
May 8, 2025 06:31AM Veru, Inc. (VERU) Tops Q2 EPS by 1c
Feb 14, 2025 09:07AM Veru, Inc. (VERU) PT Lowered to $4 at Oppenheimer
Feb 13, 2025 06:31AM Veru, Inc. (VERU) Tops Q1 EPS by 2c
Jan 27, 2025 01:53PM Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
Jan 27, 2025 06:30AM Veru, Inc. (VERU) Announces Positive Topline Data from Phase 2b QUALITY Clinical Study
Jan 24, 2025 09:07AM Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU) as Key Catalyst Approaches
Jan 2, 2025 10:13AM Increasing unusual put option volume: RGTI NMRA VERU SDS FFIE QBTS PLNT QUBT TCOM
Jan 2, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Veru, Inc. (VERU)
Dec 31, 2024 08:31AM Veru, Inc. (VERU) Sells the FC2 Female Condom (Internal Condom) Business
Dec 20, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Veru, Inc. (VERU)
Nov 5, 2024 03:17PM Oppenheimer Reiterates Outperform Rating on Veru, Inc. (VERU)
Aug 8, 2024 06:32AM Veru, Inc. (VERU) Misses Q3 EPS by 1c
Jul 17, 2024 11:22AM Veru, Inc. (VERU) PT Lowered to $1 at Jefferies